Fuchs’ Endothelial Corneal Dystrophy Market

1. Introduction
   • Definition of Fuchs’ Endothelial Corneal Dystrophy Market
   • Scope of the Report
2. Methodology
   • Executive Summary
   • Market Overview
   • Market Definition and Segmentation
3. Market Dynamics
   • Drivers
   • Restraints
   • Opportunities
   • Porter's Five Forces Analysis
   • PESTEL Analysis
4. Fuchs’ Endothelial Corneal Dystrophy Market, By Treatment
   • Medication
   • Surgery
   • Others
5. Fuchs’ Endothelial Corneal Dystrophy Market, By Diagnosis
   • Cornea Examination and Grading
   • Corneal Tomography
   • Corneal Pachymetry
   • Corneal Cell Count
   • Others
6. Fuchs’ Endothelial Corneal Dystrophy Market, By Symptoms
   • Sensitivity to Light
   • Night Vision Problems
   • Swelling
   • Inability to Drive at Night
   • Gritty-like Feeling in Both Eyes
   • Pain
   • Low Vision in Humid Weather
   • Cloudy Vision
   • Appearance of Halo-like Circles Around Lights
   • Others
7. Fuchs’ Endothelial Corneal Dystrophy Market, By Dosage
   • Solutions
   • Tablet
   • Injection
   • Others
8. Fuchs’ Endothelial Corneal Dystrophy Market, By Route of Administration
   • Oral
   • Topical
   • Others
9. Fuchs’ Endothelial Corneal Dystrophy Market, By Distribution Channel
   • Hospital Pharmacy
   • Retail Pharmacy
   • Online Pharmacy
10. Fuchs’ Endothelial Corneal Dystrophy Market, By End-Users
    • Clinic
    • Hospital
    • Others
11. Fuchs’ Endothelial Corneal Dystrophy Market, By Geography
    • North America
      • United States
      • Canada
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • Saudi Arabia
      • United Arab Emirates
      • South Africa
      • Rest of Middle East & Africa
12. Competitive Landscape
13. Company Profiles
    • Kowa Company, Ltd.
      • Company Overview
      • Product Portfolio and Description
      • Key Highlights
      • Financial Overview
    • Trefoil Therapeutics
    • AERIE PHARMACEUTICALS, INC.
    • Price Vision Group
    • ProQR Therapeutics
    • Emmecell
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Bausch Health Companies Inc.
    • Bayer AG
    • Allergan
    • Teva Pharmaceutical Industries Ltd.
    • Merck & Co., Inc.
    • Novartis AG
14. Conclusion and Future Outlook
15. Appendix
    • Research Methodology
    • About the Pharmanucleus

16. Disclaimer